Taken together, these results indicate that salinomycin reduces the expression of key prostate cancer oncogenes and AR signalling as well as causes alterations in steroid biosynthesis, cell-cycle checkpoint regulation, AhR signalling and oxidative stress response in prostate cancer cells. This evidence concerns the gene AR and prostate carcinoma.